[Federal Register Volume 84, Number 107 (Tuesday, June 4, 2019)]
[Notices]
[Pages 25809-25810]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-11548]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 84 FR 14739-14381, dated April 10, 2019) is
amended to reflect the reorganization of the Office of the Associate
Director for Policy and Strategy, Office of the Director, Centers for
Disease Control and Prevention. This reorganization abolishes the
Office of Health System Collaboration and establishes the Office of
Population Health and Healthcare.
Section C-B, Organization and Functions, is hereby amended as
follows:
Delete in its entirety the functional statement for the Office of
the Associate Director for Policy and Strategy (CAQ), and insert the
following:
Office of the Associate Director for Policy and Strategy (CAQ). The
mission of CDC's Office of the Associate Director for Policy and
Strategy (OADPS) is to bring about, define and evaluate policies and
strategies that result in demonstrable improvements in public health--
globally and at the federal, state, and local levels. In carrying out
its mission, OADPS: (1) Provides advice to CDC leadership in developing
agency policies, programs, and strategies; (2) creates and maintains
partnerships to implement policies, programs, and
[[Page 25810]]
strategies; (3) monitors and evaluates programs to improve the public's
health; and (4) ensures the agency's scientific credibility,
reputation, and needs are respected and supported by policy makers,
program partners, and stakeholders.
Delete in its entirety the functional statement for the Office of
the Director (CAQ1), and insert the following:
Office of the Director (CAQ1). (1) Provides strategic advice to CDC
leadership on agency direction and drives CDC towards actions to reduce
leading preventable causes of morbidity and mortality; (2) ensures
effectiveness of policy, program, performance, and strategy across the
agency; (3) builds capacity throughout CDC for policy, program,
performance, and strategy; (4) leads the development and management of
policy and programmatic agendas with federal agencies and other
organizations; (5) establishes and maintains strategic partnerships
with key organizations and individuals working on public health
policies and programs.
Delete in its entirety the title and functional statement for the
Office of Health System Collaboration (CAQ12).
Delete in its entirety the functional statement for the Policy
Research, Analysis, and Development Office (CAQB), and insert the
following:
Policy Research, Analysis, and Development Office (CAQB). (1)
Identifies and assists CDC leadership in informing policy at multiple
levels (e.g., federal, state, local, global, and private sector); (2)
gathers and disseminates knowledge about statutes, regulations, and
sub-regulatory guidance that can increase the policy impact of CDC
programs; (3) conducts analyses, including regulatory, legal, and
economic and develops strategies for CDC policy priorities; (4)
supports policy implementation through the provision of expertise,
guidance, reviews, and tools; (5) monitors and evaluates the impact of
CDC policies; (6) builds policy analysis and development capacity
within CDC and the larger public health community; (7) leads CDC's
public health policy research agenda; (8) manages selected partner
cooperative agreements and contracts that focus on policy; and (9)
incubates innovative programs that emerge from policy priorities
identified by CDC leadership.
Delete in its entirety the Program Performance and Evaluation
Office (CAQD) and insert the following:
Program Performance and Evaluation Office (CAQD). (1) Serves as an
advisor to CDC leadership on program effectiveness to guide science,
policy, and programmatic efforts; (2) provides agency-wide direction,
standards, and technical assistance for program planning, performance
and accountability; (3) supports the harmonization of performance
measurement, accountability, and program evaluation; (4) guides the
collection and analysis of economic, performance, and accountability
data; (5) facilitates continuous improvement based on program
evaluation and performance measurement; (6) manages the CDC evaluation
fellowship; (7) provides economic evaluation support to CDC leadership;
(8) drives short-term and long-term strategic program planning; (9)
supports evidence-driven program design with expertise, analyses, and
tools; (10) promotes standardization of shared programmatic activities
to improve efficiency; (11) coordinates action planning for high impact
initiatives; and (12) facilitates information sharing and collaboration
between programs and CDC leadership.
After the functional statement for the Program Performance and
Evaluation Office (CAQD), insert the following:
Office of Population Health and Healthcare (CAQE). (1) Engages
multi-sectoral partners (e.g., private sector, non-profit,
transportation, housing, healthcare providers and insurance plans,
foundations) to create collaborative opportunities that improve health
outcomes; (2) uses data, subject matter expertise and convening power
to inform the development of policies, programs and tools; (3) provides
agency wide guidance on approaches and partners that can help achieve
CDC aims; (4) builds capacity to use CDC data analysis and
interpretation expertise to explore gaps in health outcomes and develop
population health/healthcare solutions; and (5) creates linkages and
synergies between CDC programs to maximize population health impact.
Sherri A. Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-11548 Filed 6-3-19; 8:45 am]
BILLING CODE 4160-18-P